This article addresses the system of intellectual property law in Brazil and its relation to the country's policy of universal access to AIDS medicines. It also presents the key working strategies of a Brazilian civil society group - GTPI/REBRIP - to tackle the main problems and challenges that are identified.
Intellectual property; Essential medicines; HIV/AIDS; Civil society; TRIPS
